Waste­water Mi­cro­bi­ol­ogy

by Me­chas

Us­ing waste­water to mon­i­tor hu­man pop­u­la­tions is a grow­ing trend. The waste prod­ucts found in this wa­ter, dis­carded af­ter do­mes­tic, com­mer­cial, or in­dus­trial use, re­flect the habits and con­sump­tions of so­ci­ety and pro­vide a pool of in­for­ma­tion on our cus­toms and be­hav­iors. The re­cent surge in in­ter­est on an­a­lyz­ing waste­water stems from its value for prob­ing pathogens and in­form­ing on health con­cerns that aid pub­lic health de­ci­sions.

The Cloaca Max­ima un­der the Ro­man Fo­rum, photo credit Marco Gradozzi. Source

Arche­o­log­i­cal re­mains in­di­cate that dis­pos­ing of hu­man wastes and waste­water has trou­bled peo­ple for mil­len­nia. Sys­tems to re­move wastes from ur­ban cen­ters were present in the Mesopotamian Em­pire, in An­cient Greece, and, of course, in Rome. Ro­mans, who ex­celled as ar­chi­tects and en­gi­neers, con­structed com­plex sys­tems to both trans­port wa­ter and re­move waste­water from ur­ban cen­ters, an ex­am­ple of the lat­ter be­ing the large and im­pres­sive Cloaca Max­ima. But more of­ten than not, wastes were dis­posed of in streets and pub­lic places, fre­quently re­sult­ing in se­ri­ous health prob­lems and pan­demics, as oc­curred through­out Eu­rope dur­ing the Mid­dle Ages.

Only un­til re­cently in hu­man his­tory have we un­der­stood the im­por­tance of waste­water man­age­ment and san­i­ta­tion to pub­lic health. And even more re­cently have we re­al­ized the value of us­ing waste­water for pathogen sur­veil­lance. Track­ing pathogens in waste­water rose to promi­nence dur­ing the COVID-19 pan­demic as an eas­ily ac­ces­si­ble scheme for prob­ing nearby pop­u­la­tions with­out in­va­sive test­ing. This ap­proach was quickly im­ple­mented in many coun­tries as a rapid and cost-ef­fec­tive strat­egy for com­mu­nity sur­veil­lance, pro­vid­ing early warn­ing of pos­si­ble SARS-CoV‑2 out­breaks. Since then, in­ter­est in waste­water-based epi­demi­ol­ogy has surged. The sen­si­tiv­ity of mol­e­c­u­lar meth­ods, par­tic­u­larly tar­geted PCR tech­niques and metage­nomic se­quenc­ing, can ac­cu­rately iden­tify po­ten­tial pathogens and other threats to pub­lic health.

De­spite this re­cent burst of ac­tiv­ity, the use of ur­ban sewage to track viruses is not new. Waste­water was used as early as 1939 to track po­liovirus. Only much later, in 2003, was waste­water-based epi­demi­ol­ogy for­mally rec­og­nized by the World Health Or­ga­ni­za­tion and by 2020, when we were hit by the COVID-19 pan­demic, it was an es­tab­lished and re­li­able method for pub­lic health mon­i­tor­ing. To­day, it is used to iden­tify other vi­ral pathogens like in­fluenza virus and res­pi­ra­tory syn­cy­tial virus. But waste­water con­tains more than just pathogens. It has been used re­cently, for ex­am­ple, to mon­i­tor con­sump­tion trends, such as il­licit drug use, and to de­ter­mine the pres­ence and spread of an­tibi­otic-re­sis­tance genes.

Waste­water has played at least one other promi­nent role in mi­cro­bi­ol­ogy. It was at the root of work done by the Phage Group and thus crit­i­cal in the early his­tory of mol­e­c­u­lar ge­net­ics. As de­scribed in a pre­vi­ous post , the physi­cist Max Del­brück met Emory El­lis at Cal­tech. Be­fore meet­ing Del­brück, El­lis was al­ready work­ing with phages. His aim was to repli­cate and ex­pand Fe­lix d'Hérelle's growth ex­per­i­ments which in­di­cated that phages were par­a­sites – anal­o­gous to plant and an­i­mal viruses – that mul­ti­plied in bac­te­ria. For this, El­lis sam­pled a site likely to con­tain phages: the sewage sys­tem of Pasadena, Cal­i­for­nia. W.C. Sum­mers doc­u­ments this in a pa­per on the use of bac­te­rio­phage by the Phage Group: "El­lis, to­gether with his wife, Mar­ion El­lis, ob­tained some sewage from the Pasadena sewage treat­ment plant and, fol­low­ing d'Herelle's meth­ods, iso­lated a phage ac­tive on E. coli."

The en­counter be­tween Del­brück and El­lis set the stage for us­ing E. coli and its phages as a key model sys­tem, work that proved foun­da­tional for mol­e­c­u­lar bi­ol­ogy. But why did Emory El­lis se­lect E. coli? This serendip­i­tous choice will be ex­plained in next Monday's post. Stay tuned.

 

Do you want to com­ment on this post? We would be happy about it! Please send us an email, or com­ment on Mastodon, or ob Bluesky.
 

Other Posts

  • How E. coli Rose to Promi­nence – Just One More Ad­den­dum (1|2)

    by Christoph — While Roberto looked deep into the fas­ci­nat­ing past of 'How E. coli rose to promi­nence' in two of his re­cent posts, I will take a look around ahead here in 'Just One More Ad­den­dum', and a wider look around in 'Again, One More Ad­den­dum' in an up­com­ing post. But that was it for the time be­ing with this 'Ecol­i­ma­nia' here in STC...

  • On Old Age

    by Elio — In a cou­ple of months, my age will be di­vis­i­ble by 31 (no, I won't be 62 years old, nor 124). Does this level of senec­ti­tude give me per­mis­sion to muse about hav­ing be­come an "old sci­en­tist?" What do you think?
     

  • Move Over, DNA

    by Merry Youle — For 50 years, re­searchers have mulled over why D. ra­dio­du­rans is able to sur­vive 100 times more ion­iz­ing ra­di­a­tion (IR) than other bac­te­ria, 2000 times more than a hu­man be­ing. Al­though both DNA and pro­teins are dam­aged by IR, DNA was widely re­garded as the crit­i­cal tar­get. That D. ra­dio­du­rans can suf­fer 100 dou­ble strand DNA breaks per genome sug­gests...

  • Be­hind the Sci­ence

    by Elio — Re­cently, I had the plea­sure of par­tic­i­pat­ing in a pro­gram called "Peo­ple Be­hind the Sci­ence." This is a se­ries of in­ter­views con­ducted by Marie Mc­Neely, a neu­ro­sci­en­tist who hosts this re­mark­able en­deavor. The pro­gram aims to pro­vide a can­did look at the lives of sci­en­tists across a va­ri­ety of fields and to show­case the hu­man side of sci­ence. Marie asks a bunch of prob­ing ques­tions that re­veal more than "the per­son in the white lab coat."